| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comparative approach to policy analysis: Health care policy in four nations
|
Fortress, Eric
|
|
1982
|
|
3 |
p. 286-
1 p.
|
artikel
|
| 2 |
Adenosine triphosphate for cancer cachexia
|
Walsh, T. Declan
|
|
2002
|
|
3 |
p. 231-232
|
artikel
|
| 3 |
Adjuvant and preoperative chemotherapy for gastric cancer
|
Yao, James C.
|
|
2002
|
|
3 |
p. 222-228
|
artikel
|
| 4 |
Adjuvant chemotherapy for transitional cell carcinoma of the bladder: Paradigms for the design of clinical trials
|
Boyar, Michelle
|
|
2005
|
|
3 |
p. 207-214
|
artikel
|
| 5 |
Adjuvant therapy for colon cancer
|
Cilley, Jeffrey
|
|
2006
|
|
3 |
p. 161-166
|
artikel
|
| 6 |
Adjuvant therapy for colon cancer
|
Sun, Weijing
|
|
2005
|
|
3 |
p. 181-185
|
artikel
|
| 7 |
Angiogenesis and prostate cancer: Important laboratory and clinical findings
|
Cox, Michael C.
|
|
2005
|
|
3 |
p. 215-219
|
artikel
|
| 8 |
Artificial neural networks for predictive modeling in prostate cancer
|
Gamito, Eduard J.
|
|
2004
|
|
3 |
p. 216-221
|
artikel
|
| 9 |
Barrett’s esophagus and Barrett’s carcinoma
|
Rahden, Burkhard H. A. von
|
|
2003
|
|
3 |
p. 203-209
|
artikel
|
| 10 |
Biomarkers as surrogates for cancer development
|
Hawk, Ernest
|
|
2000
|
|
3 |
p. 242-250
|
artikel
|
| 11 |
Black health inequities and the American health care system
|
Rice, Mitchell F.
|
|
1982
|
|
3 |
p. 195-214
20 p.
|
artikel
|
| 12 |
Chemoradiotherapy for gastrointestinal cancers
|
Rich, Tyvin A.
|
|
2005
|
|
3 |
p. 196-202
|
artikel
|
| 13 |
Chemotherapeutic advances in pancreatic cancer
|
Berlin, Jordan D.
|
|
2003
|
|
3 |
p. 219-226
|
artikel
|
| 14 |
Chemotherapy for advanced pancreatic cancer: Past, present, and future
|
Friberg, Gregory
|
|
2005
|
|
3 |
p. 186-195
|
artikel
|
| 15 |
Chemotherapy for advanced prostate cancer: Results of new clinical trials and future studies
|
Armstrong, Andrew J.
|
|
2005
|
|
3 |
p. 220-227
|
artikel
|
| 16 |
Chemotherapy-induced peripheral neuropathy: An increasing concern for oncologists
|
Markman, Maurie
|
|
2005
|
|
3 |
p. 159-160
|
artikel
|
| 17 |
Clinical trials in metastatic hormone-refractory prostate cancer: Improving docetaxel therapy by targeting bone-related growth factors
|
Petrylak, Daniel P.
|
|
2007
|
|
3 |
p. 211-212
|
artikel
|
| 18 |
Clinical Trials Report
|
Portlock, Carol S.
|
|
2001
|
|
3 |
p. 241-242
|
artikel
|
| 19 |
Combination chemotherapy for ovarian cancer-lessons not yet learned?
|
Kaye, Stanley B.
|
|
2002
|
|
3 |
p. 185-186
|
artikel
|
| 20 |
Combined chemotherapy and external beam radiotherapy for transitional cell carcinoma of the bladder
|
Ennis, Ronald D.
|
|
2004
|
|
3 |
p. 230-236
|
artikel
|
| 21 |
Combined-modality therapy for esophageal and gastroesophageal junction cancers
|
Yoon, Harry H.
|
|
2007
|
|
3 |
p. 184-192
|
artikel
|
| 22 |
Community medicine: The “first-born” of a marriage between medical education and medical care
|
Prywes, Moshe
|
|
1980
|
|
3 |
p. 291-300
10 p.
|
artikel
|
| 23 |
Complications of androgen deprivation therapy in men with prostate cancer
|
Chen, Allen C.
|
|
2004
|
|
3 |
p. 209-215
|
artikel
|
| 24 |
Contributors to this issue
|
|
|
1980
|
|
3 |
p. 301-
1 p.
|
artikel
|
| 25 |
Contributors to this issue
|
|
|
1982
|
|
3 |
p. 287-288
2 p.
|
artikel
|
| 26 |
Cost containment: Is it unjustly cutting therapeutic mental health services? The plight of neighborhood organizations
|
Spiegel, Allen D.
|
|
1980
|
|
3 |
p. 255-269
15 p.
|
artikel
|
| 27 |
Current and future strategies for combined-modality therapy in pancreatic cancer
|
Ko, Andrew H.
|
|
2002
|
|
3 |
p. 202-212
|
artikel
|
| 28 |
Diagnosis, prognosis, and therapy in hematologic cancers: Macro expectations for microarrays
|
Scheinberg, David A.
|
|
2001
|
|
3 |
p. 191-192
|
artikel
|
| 29 |
Diet and prevention of colorectal cancer
|
Ritenbaugh, Cheryl
|
|
2000
|
|
3 |
p. 225-233
|
artikel
|
| 30 |
Docetaxel-based chemotherapy trials in androgen-independent prostate cancer: First demonstration of a survival benefit
|
Petrylak, Daniel P.
|
|
2005
|
|
3 |
p. 205-206
|
artikel
|
| 31 |
Early chemohormonal therapy in prostate cancer: Preliminary data and randomized trials
|
Petrylak, Daniel P.
|
|
2003
|
|
3 |
p. 229-230
|
artikel
|
| 32 |
Early-stage hodgkin’s disease
|
Josting, Andreas
|
|
2001
|
|
3 |
p. 279-284
|
artikel
|
| 33 |
Epidemiology of tobacco carcinogenesis
|
Shields, Peter G.
|
|
2000
|
|
3 |
p. 257-262
|
artikel
|
| 34 |
Fenretinide and cancer prevention
|
Torrisi, Rosalba
|
|
2000
|
|
3 |
p. 263-270
|
artikel
|
| 35 |
First-line therapy for advanced colorectal cancer
|
Gramont, Aimery de
|
|
2005
|
|
3 |
p. 167-172
|
artikel
|
| 36 |
Gastric cancer: An update
|
Shah, Manish A.
|
|
2006
|
|
3 |
p. 183-191
|
artikel
|
| 37 |
Gastric carcinoma
|
Phan, Alexandria T.
|
|
2004
|
|
3 |
p. 192-198
|
artikel
|
| 38 |
Gene expression profiling of lymphomas
|
Hegde, Upendra
|
|
2001
|
|
3 |
p. 243-249
|
artikel
|
| 39 |
Genetic polymorphism and cancer risk
|
Clapper, Margie L.
|
|
2000
|
|
3 |
p. 251-256
|
artikel
|
| 40 |
Health care delivery in the United States
|
Bloom, Bernard S.
|
|
1982
|
|
3 |
p. 285-
1 p.
|
artikel
|
| 41 |
Hepatocellular carcinoma: Epidemic and treatment
|
Allen, Jill
|
|
2004
|
|
3 |
p. 177-183
|
artikel
|
| 42 |
HIV-Associated lymphomas
|
Straus, David J.
|
|
2001
|
|
3 |
p. 260-265
|
artikel
|
| 43 |
Imatinib-refractory gastrointestinal stromal tumors: The clinical problem and therapeutic strategies
|
Mehren, Margaret von
|
|
2006
|
|
3 |
p. 192-197
|
artikel
|
| 44 |
Immunotherapy for prostate cancer
|
Fong, Lawrence
|
|
2007
|
|
3 |
p. 226-233
|
artikel
|
| 45 |
Improving the selection of family medicine residents through development of multi-dimensional policy models
|
Parker, Barnett R.
|
|
1982
|
|
3 |
p. 229-247
19 p.
|
artikel
|
| 46 |
Intergovernmental relations in physician education and health planning: State adoption decisions and the impact of federal programs
|
Durand, Roger
|
|
1982
|
|
3 |
p. 269-283
15 p.
|
artikel
|
| 47 |
Issues and opportunities in the regulation of home health care
|
Spiegel, Allen D.
|
|
1980
|
|
3 |
p. 237-253
17 p.
|
artikel
|
| 48 |
Laryngeal preservation: What is the best treatment strategy?
|
Hanna, Ehab Y.
|
|
2004
|
|
3 |
p. 167-169
|
artikel
|
| 49 |
Leukemia vaccines
|
Kochenderfer, James N.
|
|
2001
|
|
3 |
p. 193-200
|
artikel
|
| 50 |
Literature alert
|
|
|
2003
|
|
3 |
p. 179-180
|
artikel
|
| 51 |
Literature alert
|
|
|
2001
|
|
3 |
p. 186-187
|
artikel
|
| 52 |
Literature Alert
|
Pfister, DAvid G.
|
|
2000
|
|
3 |
p. 213-219
|
artikel
|
| 53 |
Literature alert
|
|
|
2002
|
|
3 |
p. 188-189
|
artikel
|
| 54 |
Litrature alert
|
|
|
2004
|
|
3 |
p. 172-174
|
artikel
|
| 55 |
Management of asymptomatic rise in prostatic-specific antigen in patients with prostate cancer
|
Mohile, Supriya G.
|
|
2006
|
|
3 |
p. 213-220
|
artikel
|
| 56 |
Models of chronic myeloid leukemia
|
Etten, Richard A. Van
|
|
2001
|
|
3 |
p. 228-237
|
artikel
|
| 57 |
Multimodality treatment of esophageal cancer: A review of the current status and future directions
|
Ng, Thomas
|
|
2006
|
|
3 |
p. 174-182
|
artikel
|
| 58 |
Mutual benefits in hospital-based clinical education for the allied health professions: A position
|
McLeod, Marshall W.
|
|
1980
|
|
3 |
p. 217-220
4 p.
|
artikel
|
| 59 |
Neoadjuvant chemoimmunotherapy in locally advanced breast cancer: A new avenue to be explored
|
Buter, Jan
|
|
2003
|
|
3 |
p. 171-176
|
artikel
|
| 60 |
Neoadjuvant therapy for high-risk localized prostate cancer
|
Yu, Evan Y.
|
|
2003
|
|
3 |
p. 250-257
|
artikel
|
| 61 |
New developments in therapy for colorectal cancer
|
Gill, Sharlene
|
|
2003
|
|
3 |
p. 183-191
|
artikel
|
| 62 |
New developments in the treatment of esophageal cancer
|
Ilson, David H.
|
|
2002
|
|
3 |
p. 213-221
|
artikel
|
| 63 |
New developments in the treatment of gastrointestinal neuroendocrine tumors
|
Kulke, Matthew H.
|
|
2007
|
|
3 |
p. 177-183
|
artikel
|
| 64 |
New drug development in non-hodgkin lymphomas
|
Cheson, Bruce D.
|
|
2001
|
|
3 |
p. 250-259
|
artikel
|
| 65 |
New drugs for the anorexia-cachexia syndrome
|
Davis, Mellar P.
|
|
2002
|
|
3 |
p. 264-274
|
artikel
|
| 66 |
New treatments for superficial bladder cancer
|
Shah, Jay B.
|
|
2006
|
|
3 |
p. 201-205
|
artikel
|
| 67 |
Novel therapies for pancreatic adenocarcinoma
|
Pino, Simona M.
|
|
2004
|
|
3 |
p. 199-206
|
artikel
|
| 68 |
Novel treatment strategies in chronic lymphocytic leukemia
|
Weiss, Mark A.
|
|
2001
|
|
3 |
p. 217-222
|
artikel
|
| 69 |
Nutrition and diet in the development of gastrointestinal cancer
|
Thomson, Cynthia A.
|
|
2003
|
|
3 |
p. 192-202
|
artikel
|
| 70 |
Pancreatic cancer: An update
|
Kindler, Hedy Lee
|
|
2007
|
|
3 |
p. 170-176
|
artikel
|
| 71 |
Positron emission tomography and gallium metabolic imaging in lymphoma
|
Coiffier, Bertrand
|
|
2001
|
|
3 |
p. 266-270
|
artikel
|
| 72 |
Postgraduate and continuing medical education in Finland
|
Jääskeläinen, Manu
|
|
1982
|
|
3 |
p. 249-268
20 p.
|
artikel
|
| 73 |
Practical guide to palliative sedation
|
Cowan, John D.
|
|
2002
|
|
3 |
p. 242-249
|
artikel
|
| 74 |
Prenatal Epidemiology of Pediatric Tumors
|
Ross, Julie A.
|
|
2000
|
|
3 |
p. 234-241
|
artikel
|
| 75 |
Preoperative and adjuvant treatment of localized rectal cancer
|
Das, Prajnan
|
|
2006
|
|
3 |
p. 167-173
|
artikel
|
| 76 |
Preventing relapse in melanoma
|
Stebbing, Justin
|
|
2000
|
|
3 |
p. 205-208
|
artikel
|
| 77 |
Quality assurance in oncology: More substance, more questions
|
Markman, Maurie
|
|
2006
|
|
3 |
p. 155-156
|
artikel
|
| 78 |
Radioisotopic treatment of bone pain from metastatic prostate cancer
|
Sartor, Oliver
|
|
2003
|
|
3 |
p. 258-262
|
artikel
|
| 79 |
Rationale for, and approach to, studying modifiers of risk in persons with a genetic predisposition to colorectal cancer
|
Jenkins, Mark A.
|
|
2007
|
|
3 |
p. 202-207
|
artikel
|
| 80 |
Recent advances in therapy for gastrointestinal stromal tumors
|
Maki, Robert G.
|
|
2007
|
|
3 |
p. 165-169
|
artikel
|
| 81 |
Recent developments in barrett’s esophagus
|
Garewal, Harinder S.
|
|
2000
|
|
3 |
p. 271-276
|
artikel
|
| 82 |
Recent developments in the treatment of gastric carcinoma
|
Shah, Manish A.
|
|
2002
|
|
3 |
p. 193-201
|
artikel
|
| 83 |
Relationship between accreditation status and hourly wages of Medical Record Technicians
|
Marron, Michael
|
|
1982
|
|
3 |
p. 215-221
7 p.
|
artikel
|
| 84 |
Secondary hormonal manipulations in prostate cancer
|
Ryan, Charles J.
|
|
2005
|
|
3 |
p. 228-233
|
artikel
|
| 85 |
Second-line therapy for advanced colorectal carcinoma
|
Starling, Naureen
|
|
2005
|
|
3 |
p. 173-180
|
artikel
|
| 86 |
Selection of applicants for medical school admission
|
Fruen, Mary A.
|
|
1980
|
|
3 |
p. 221-236
16 p.
|
artikel
|
| 87 |
Shifting from clinical to biologic indicators of prognosis after resection of hepatic colorectal metastases
|
Pawlik, Timothy M.
|
|
2007
|
|
3 |
p. 193-201
|
artikel
|
| 88 |
Some challenges in the management of community Health Education
|
Timmreck, Thomas C.
|
|
1982
|
|
3 |
p. 223-228
6 p.
|
artikel
|
| 89 |
Status of treatment for advanced gastric carcinoma
|
Tsai, James Y.
|
|
2003
|
|
3 |
p. 210-218
|
artikel
|
| 90 |
STI571: A gene product-targeted therapy for leukemia
|
Mauro, Michael J.
|
|
2001
|
|
3 |
p. 223-227
|
artikel
|
| 91 |
Surgical palliation in advanced disease: Recent developments
|
Dunn, Geoffrey P.
|
|
2002
|
|
3 |
p. 233-241
|
artikel
|
| 92 |
Symptom assessment in cancer patients
|
Naughton, Michael
|
|
2002
|
|
3 |
p. 256-263
|
artikel
|
| 93 |
Targeted approaches for the management of metastatic prostate cancer
|
Beekman, Kathleen W.
|
|
2006
|
|
3 |
p. 206-212
|
artikel
|
| 94 |
Targeting osseous metastases: Rationale and development of radioimmunotherapy for prostate cancer
|
Morris, Michael J.
|
|
2004
|
|
3 |
p. 222-229
|
artikel
|
| 95 |
The biology of acute promyelocytic leukemia
|
Mann, Koren K.
|
|
2001
|
|
3 |
p. 209-216
|
artikel
|
| 96 |
The current and potential role of cryoablation as a primary therapy for localized prostate cancer
|
Katz, Aaron E.
|
|
2003
|
|
3 |
p. 231-238
|
artikel
|
| 97 |
The effect of economic incentives on the education and distribution of physicians: A review
|
Scheffler, Richard M.
|
|
1980
|
|
3 |
p. 271-289
19 p.
|
artikel
|
| 98 |
The evolving role of partial nephrectomy in the management of renal cell carcinoma
|
Gilbert, Scott M.
|
|
2003
|
|
3 |
p. 239-244
|
artikel
|
| 99 |
Therapy for fungal infections in leukemia
|
Segal, Robert E.
|
|
2001
|
|
3 |
p. 201-208
|
artikel
|
| 100 |
The role of bisphosphonates in the management of metastatic prostate cancer
|
Michaelson, M. Dror
|
|
2003
|
|
3 |
p. 245-249
|
artikel
|
| 101 |
The role of bisphosphonates in the management of prostate cancer
|
Saad, Fred
|
|
2006
|
|
3 |
p. 221-227
|
artikel
|
| 102 |
The role of C-reactive protein as a prognostic indicator in advanced cancer
|
Mahmoud, Fade Aziz
|
|
2002
|
|
3 |
p. 250-255
|
artikel
|
| 103 |
The role of high-intensity focused ultrasound in prostate cancer
|
Lynch, John H.
|
|
2007
|
|
3 |
p. 222-225
|
artikel
|
| 104 |
The role of lymphadenectomy in patients undergoing radical cystectomy for bladder cancer
|
Stein, John P.
|
|
2007
|
|
3 |
p. 213-221
|
artikel
|
| 105 |
The use of herbal and over-the-counter dietary supplements for the prevention of prostate cancer
|
Bemis, Debra L.
|
|
2006
|
|
3 |
p. 228-236
|
artikel
|
| 106 |
Treatment of hepatocarcinoma
|
Gerard, Beatrice
|
|
2004
|
|
3 |
p. 184-191
|
artikel
|
| 107 |
Upfront transplantation for poor-risk aggressive non-hodgkin lymphoma and hodgkin’s disease: Who benefits?
|
Kewalramani, Tarun
|
|
2001
|
|
3 |
p. 271-278
|
artikel
|
| 108 |
Use of progression-free survival as a valid endpoint in phase II cancer clinical trials
|
Markman, Maurie
|
|
2007
|
|
3 |
p. 159-160
|
artikel
|
| 109 |
Web alert
|
|
|
2004
|
|
3 |
p. 170-171
|
artikel
|
| 110 |
Web alert
|
|
|
2001
|
|
3 |
p. 188
|
artikel
|
| 111 |
Web alert
|
|
|
2006
|
|
3 |
p. 157-158
|
artikel
|
| 112 |
Web Alert
|
|
|
2000
|
|
3 |
p. 209-211
|
artikel
|
| 113 |
Web alert
|
|
|
2002
|
|
3 |
p. 190
|
artikel
|
| 114 |
Web alert
|
|
|
2007
|
|
3 |
p. 161
|
artikel
|
| 115 |
Web alert
|
|
|
2003
|
|
3 |
p. 177-178
|
artikel
|
| 116 |
Web alert
|
|
|
2005
|
|
3 |
p. 161-163
|
artikel
|
| 117 |
What’s new in the field of prostate cancer chemoprevention?
|
Mahal, Kanwaljit
|
|
2004
|
|
3 |
p. 237-242
|
artikel
|
Tijdschrift beschrijving